About Michael Taglich
Michael Taglich is a director at Dilon Technologies.
Form D filings also name Michael Taglich as a director at BioVentrix.
Michael Taglich first appears on SEC filings in 2008.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Taglich in the role, so the role may have started earlier or lasted longer.
Dilon Technologies Inc.
Director
2008 – 2026 · Newport News, VA
Dilon makes medical devices for healthcare providers, including tools for breast cancer surgery.
Bioventrix, Inc.
Director
2009 – 2025 · Mansfield, MA
Develops an investigational heart device for surgeons treating patients with heart failure.
Key Colleagues at Startups
The people Michael Taglich works with at each company, as listed on that company's latest Form D.
Dilon Technologies Inc. · Form D/A, Mar 11, 2026
RM
Robert Moussa
Director
RB
Rachel Brem
Director
RT
Robert Taglich
Director
FB
Francis Bissaillon
Director
TJ
Tim Jette
Executive officer
GM
George Makhoul
CEO and director
Bioventrix, Inc. · Form D/A, Nov 4, 2025
William Abraham
Director
Steven Chartier
President and Co-Chief Executive Officer, director
Rishi Puri
Director
David Richmond
Co-Chief Executive Officer and director
MR
Mark Ravich
Independent Board Member